Evidence map›Paper›PMID 35967853›Full record

ArticleFrontiers in cellular and infection microbiology2022

Gut microbiome is associated with metabolic syndrome accompanied by elevated gamma-glutamyl transpeptidase in men.

Shifeng Sheng, Su Yan, Jingfeng Chen, Yuheng Zhang, Youxiang Wang, Qian Qin, Weikang Li, Tiantian Li, Meng Huang, Suying Ding and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 43 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Animals : an open access journal from MDPI · 2025
    Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Shifeng ShengHealth Management Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Su YanHealth Management Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Jingfeng ChenHealth Management Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Yuheng ZhangHealth Management Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Youxiang WangHealth Management Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Qian QinHealth Management Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Weikang LiHealth Management Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Tiantian LiHealth Management Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Meng HuangHealth Management Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Suying DingHealth Management Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Lin TangDepartment of Nephropathy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
First Affiliated Hospital of Zhengzhou University · CNZhengzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It is predicted that by 2035, metabolic syndrome (MS) will be found in nearly more than half of our adult population, seriously affecting the health of our body. MS is usually accompanied by the occurrence of abnormal liver enzymes, such as elevated gamma-glutamyl transpeptidase (GGT). More and more studies have shown that the gut microbiota is involved in MS; however, the correlation between gut microbiota and MS with elevated GGT has not been studied comprehensively. Especially, there are few reports about its role in the physical examination of the population of men with MS and elevated GGT. By using the whole-genome shotgun sequencing technology, we conducted a genome-wide association study of the gut microbiome in 66 participants diagnosed as having MS accompanied by high levels of GGT (case group) and 66 participants with only MS and normal GGT level (control group). We found that the number of gut microbial species was reduced in participants in the case group compared to that of the control group. The overall microbial composition between the two groups is of significant difference. The gut microbiota in the case group is characterized by increased levels of "harmful bacteria" such as

Indexed as

gamma-GlutamyltransferaseGastrointestinal MicrobiomeMetabolic SyndromeAdultGenome-Wide Association StudyHumansMalePolyaminesgamma-GlutamyltransferasePolyaminesendogenous alcoholglutamyl transpeptidasegut microbiotametabolic pathwaymetabolic syndromemetagenomicspolyamine

Identifiers

PMID35967853
PMCPMC9373028
OpenAlexW4288535891

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.